Rana F. Hamdy

Deputy Editor-In-Chief at Egypt Today

Featured in: Favicon

egypttoday.com Favicon

mdpi.com

aap.org

thelancet.com Favicon

contagionlive.com Favicon

jpeds.com

infectioncontroltoday.com Favicon

contemporaryobgyn.net Favicon

contemporarypediatrics.com Favicon

drugtopics.com + 2 more

Articles

Identification of Lower Respiratory Tract Pathogens in Cancer Patients: Insights into Fatal Outcomes

Aug 16, 2024 | mdpi.com | Dalia F. Mourad |Samah I. Radwan |Rana F. Hamdy |Dina M. Elkhashab

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Clinical Profiles, Laboratory Biomarkers, and Mortality in Cancer Patients with Lower Respiratory Tract Infections: A Prospective Cohort Study

May 29, 2024 | mdpi.com | Samah I. Radwan |Rana F. Hamdy |Mahmoud M. Kamel |Dalia F. Mourad

All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.
Health Care Workers Can be Part of the Climate Change Solution

Oct 31, 2023 | drugtopics.com | Shreya Doshi |Rana F. Hamdy

In her session, “Climate change is a pandemic: decreasing emissions is the vaccine we need to be part of the solution. Healthcare workers: Being part of the solution at the local level,” Preeti Jaggi, MD, professor of pediatrics at Emory University of School of Medicine and antimicrobial stewardship program director, spoke at IDWeek about how health care workers can be a very real part of the solution for climate change.
HPV Vaccines Have Reshaped the Epidemiological Landscape

Oct 30, 2023 | drugtopics.com | Bennett F. Waxse |Rana F. Hamdy

In her comprehensive update, "How HPV vaccination has changed HPV epidemiology and HPV-related disease," Lauri Markowitz, MD, team lead, HPV, associate director of science, from the CDC in Atlanta, Georgia, shared an in-depth analysis of the transformative impact of HPV vaccines.1Prophylactic HPV vaccines have demonstrated remarkable efficacy, exceeding 98%, and they are already proving to be effective in the prevention of anogenital warts, precancerous lesions, and cancer alike.
AI Benefits, Challenges in Infectious Disease Treatment

Oct 30, 2023 | drugtopics.com | Bennett F. Waxse |Rana F. Hamdy

At the opening plenary of IDWeek 2023, Isaac "Zak" Kohane, MD, PhD, the inaugural chair of Harvard Medical School's Department of Biomedical Informatics, engaged infectious diseases experts by discussing the potential of medical AI while also highlighting its challenges.1 Kohane, a physician-scientist renowned for his work at the intersection of artificial intelligence and precision medicine, first showcased the rapid capabilities of AI with a case study from the Undiagnosed Diseases Network...
Maternal RSV Vaccines: Updates for Health Care Providers

Oct 20, 2023 | drugtopics.com | Rana F. Hamdy

Alisa Kachikis, MD, MSc, assistant professor of obstetrics and gynecology at the University of Washington in Seattle, provided an update on maternal RSV immunizations at IDWeek 2023. Globally, she noted, respiratory syncytial virus (RSV) is associated with 33 million lower-respiratory tract infections annually and leads to death in 1 in 28 affected infants <6 months. The greatest concentration of disease burden is in low- to middle-income countries.
Improving Screening, Management of Hepatitis C in Infants and Children

Oct 19, 2023 | contagionlive.com | Bennett F. Waxse |Rana F. Hamdy

HCV incidence rates are increasing, but screening rates for the virus are not. Although highly effective treatments are available for hepatitis C, there are challenges in screening and treating the infection. IV drug use continues to be a significant factor in the rising rates of hepatitis C. To improve screening accuracy, the article highlights the use of real-time polymerase chain reaction (PCR) testing in infants, which is considered more effective than serological testing.
Maternal Group B Streptococcus Vaccines: Update

Oct 19, 2023 | drugtopics.com | Rana F. Hamdy

Flor Munoz, MD, MSc, associate professor of pediatrics at Baylor College of Medicine, provided an update on maternal Group B Streptococcus (GBS) vaccines at IDWeek 2023.1GBS is the most common cause of early and late-onset neonatal sepsis. But perhaps less well-recognized is that GBS is also an important cause of maternal infection, stillbirths, preterm births, neonatal death, and neurodevelopmental impairment.
What’s new for maternal Group B Streptococcus vaccines?

Oct 18, 2023 | contemporarypediatrics.com | Rana F. Hamdy

Maternal GBS infection leads to neonatal sepsis and various complications, especially in low-income countries where prevention is challenging. Vaccine research spans six decades, with ongoing trials. Key questions include protection correlates and necessary antibody levels. Promising phase 2 trials: GBS6 CPS vaccine and adjuvant protein-only vaccine showing potential efficacy. Recent study establishes a threshold (0.8 micrograms/L) for transferred IgG, reducing infant GBS diseases significantly.
Maternal RSV vaccines: what health care providers should know right now

Oct 18, 2023 | contemporaryobgyn.net | Rana F. Hamdy |Celeste Krewson

A version of this article initially appeared on Contemporary Pediatrics. Alisa Kachikis, MD, MSc, assistant professor of obstetrics and gynecology at the University of Washington in Seattle, provided an update on maternal RSV immunizations at IDWeek 2023. Maternal RSV immunization is a promising strategy to protect infants from respiratory syncytial virus (RSV) infections, a major global health concern.